Compare PLRX & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLRX | NTIC |
|---|---|---|
| Founded | 2015 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.6M | 81.9M |
| IPO Year | 2020 | 1996 |
| Metric | PLRX | NTIC |
|---|---|---|
| Price | $1.11 | $8.12 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.67 | N/A |
| AVG Volume (30 Days) | ★ 620.5K | 8.3K |
| Earning Date | 05-06-2026 | 04-09-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | ★ 29.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $84,234,474.00 |
| Revenue This Year | N/A | $12.49 |
| Revenue Next Year | N/A | $7.64 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.08 | $7.14 |
| 52 Week High | $1.95 | $10.03 |
| Indicator | PLRX | NTIC |
|---|---|---|
| Relative Strength Index (RSI) | 42.84 | 44.22 |
| Support Level | N/A | $7.85 |
| Resistance Level | $1.37 | $8.53 |
| Average True Range (ATR) | 0.05 | 0.30 |
| MACD | -0.00 | -0.07 |
| Stochastic Oscillator | 25.00 | 6.84 |
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.